Elizabeth Cho-Fertikh, PhD is a Co-Founder & Managing Director of MEDA Angels, a healthcare-focused angel investor group, based in WSH, DC, Philadelphia, PA and San Francisco, CA. Her 25+ year multidisciplinary career in life sciences has spanned across academia, industry, startup & angel investing sectors.  She is a trained cancer biologist with dozens of research manuscripts published in the highest impact journals, including Nature, Nature Cell Biology  & PNAS.  She served as a Scientific Review Officer administering multi-million dollar oncology and neurotrauma grant portfolios for the Dept of Defense, the Cancer Prevention Institute of TX and switched to the ‘other side’ by developing Request for Proposal grants at the NIH focused on genomics and other high throughput technologies to better understand childhood diseases.   She has been angel investing privately for over a decade and as a member of Keiretsu Forum, DC-Collaborative Angel Group and Private Access Network.  In industry, she worked in Regulatory Affairs at Macrogenics and RegenXbio supporting therapeutic FDA IND, Fast Track and related preclinical and clinical phase submissions for cancer immunotherapeutics and gene therapies.  Elizabeth established ECF Biosolutions, an advisory practice, based on her prior collective experiences, supporting early stage ventures thru pharmaceutical companies, focusing on scientific & regulatory affairs, funding, and investment due diligence.  Clients have included Amgen, Boehringer Ingelheim, Gore Medical, Becton Dickinson, Macrogenics, dozens of start-ups and angel investors.

Dr. Cho-Fertikh enjoys mentoring start-up entrepreneurs and can be seen around town at incubators including Halcyon House, Johns Hopkins FastForward, and now the Korea Innovation Center.  She received her BA from Johns Hopkins, MS from Georgetown, PhD from Thomas Jefferson Medical School, and completed her postdoctoral fellowships at the NIH and Harvard Medical School.